Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Chemotherapy-induced peripheral neuropathy #197.

Fernandez C, Mehta Z, Espenlaub A, Ellison N.

J Palliat Med. 2014 Aug;17(8):965-6. doi: 10.1089/jpm.2014.9414. Epub 2014 Jul 15. Review. No abstract available.

PMID:
25026539
2.

Chemotherapy-induced peripheral neuropathy: clinical features, diagnosis, prevention and treatment strategies.

Gutiérrez-Gutiérrez G, Sereno M, Miralles A, Casado-Sáenz E, Gutiérrez-Rivas E.

Clin Transl Oncol. 2010 Feb;12(2):81-91. doi: 10.1007/S12094-010-0474-z. Review.

PMID:
20156778
3.

Prevention of chemotherapy-induced neuropathy: leukemia inhibitory factor.

van den Bent MJ.

Clin Cancer Res. 2005 Mar 1;11(5):1691-3. No abstract available.

4.

Acetyl-L-carnitine undervalued in the treatment of chemotherapy-induced peripheral neuropathy?

van Dam DG, Beijers AJ, Vreugdenhil G.

Acta Oncol. 2016 Dec;55(12):1495-1497. Epub 2016 Sep 8. No abstract available.

PMID:
27606940
6.

Improvement of paclitaxel-induced neuropathy by substitution of docetaxel for paclitaxel.

Rose PG, Smrekar M.

Gynecol Oncol. 2003 Nov;91(2):423-5.

PMID:
14599877
7.

Chemotherapy-induced peripheral neuropathy: Current status and progress.

Brewer JR, Morrison G, Dolan ME, Fleming GF.

Gynecol Oncol. 2016 Jan;140(1):176-83. doi: 10.1016/j.ygyno.2015.11.011. Epub 2015 Nov 7. Review.

8.

Reversal of dose-limiting carboplatin-induced peripheral neuropathy with TRPM8 activator, menthol, enables further effective chemotherapy delivery.

Storey DJ, Colvin LA, Mackean MJ, Mitchell R, Fleetwood-Walker SM, Fallon MT.

J Pain Symptom Manage. 2010 Jun;39(6):e2-4. doi: 10.1016/j.jpainsymman.2010.02.004. No abstract available.

PMID:
20538177
9.

Chemotherapy-induced peripheral neuropathy: a new treatment option.

Enck RE.

Am J Hosp Palliat Care. 2012 Nov;29(7):509-11. doi: 10.1177/1049909112458578. No abstract available.

PMID:
23074287
10.

Grading of chemotherapy-induced peripheral neurotoxicity using the Total Neuropathy Scale.

Cavaletti G, Bogliun G, Marzorati L, Zincone A, Piatti M, Colombo N, Parma G, Lissoni A, Fei F, Cundari S, Zanna C.

Neurology. 2003 Nov 11;61(9):1297-300.

PMID:
14610145
11.

Chemotherapy-induced peripheral neuropathy: A need for standardization in measurement.

Dunlap B, Paice JA.

J Support Oncol. 2006 Sep;4(8):398-9. No abstract available.

PMID:
17004514
12.

Symptoms: Chemotherapy-Induced Peripheral Neuropathy.

Schneider BP, Hershman DL, Loprinzi C.

Adv Exp Med Biol. 2015;862:77-87. doi: 10.1007/978-3-319-16366-6_6. Review.

PMID:
26059930
13.

Fatal peripheral neuropathy following FLA chemotherapy.

Osborne WL, Holyoake TL, McQuaker IG, Parker AN.

Clin Lab Haematol. 2004 Aug;26(4):295-6.

PMID:
15279668
14.
15.

Chemotherapy-induced peripheral neuropathy (CIPN) and vitamin B12 deficiency.

Schloss JM, Colosimo M, Airey C, Vitetta L.

Support Care Cancer. 2015 Jul;23(7):1843-50. doi: 10.1007/s00520-015-2725-6. Epub 2015 Apr 12. No abstract available.

PMID:
25863665
16.

Calcium/magnesium infusion for oxaliplatin-induced neuropathy: protective or not?

Avan A, Avan A, Giovannetti E, Peters GJ.

J Clin Oncol. 2014 Oct 10;32(29):3341. doi: 10.1200/JCO.2014.55.1846. Epub 2014 Aug 18. No abstract available.

PMID:
25135990
17.

5-FU-induced peripheral neuropathy: a rare complication of a well-known drug.

van Laarhoven HW, Verstappen CC, Beex LV, Kappelle AC, Punt CJ.

Anticancer Res. 2003 Jan-Feb;23(1B):647-8.

PMID:
12680161
18.

Chemotherapy-induced peripheral neuropathy in pediatric cancer patients.

Gilchrist L.

Semin Pediatr Neurol. 2012 Mar;19(1):9-17. doi: 10.1016/j.spen.2012.02.011. Review.

PMID:
22641071
19.

Vinorelbine-induced acute reversible peripheral neuropathy in a patient with ovarian carcinoma pretreated with carboplatin and paclitaxel.

Scalone S, Sorio R, Bortolussi R, Lombardi D, La Mura N, Veronesi A.

Acta Oncol. 2004;43(2):209-11. No abstract available.

PMID:
15163172
20.

Toxic neuropathy in patients with pre-existing neuropathy.

Chaudhry V, Chaudhry M, Crawford TO, Simmons-O'Brien E, Griffin JW.

Neurology. 2003 Jan 28;60(2):337-40.

PMID:
12552058

Supplemental Content

Support Center